Radiation Proctitis
13
3
4
1
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 65/100
7.7%
1 terminated out of 13 trials
50.0%
-36.5% vs benchmark
15%
2 trials in Phase 3/4
0%
0 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (13)
Soft Tissue Radiation Injury; Patient Reported Evaluation in a Single Centre Cohort Study (STRIPE)
Association Between Clinical Subtypes and Prognosis in Radiation Rectal Injury
Gut Microbiome in Gynecological Cancer Patients With Pelvic Toxicity: Controls Versus Ozone Treatment. (MicrOzoGineTox)
A Phase II Single-Arm Study of High-Bioavailability Curcumin as Neoadjuvant Chemoradiotherapy in Mid-to-Low Rectal Cancer: Integrated Clinical and Translational Analysis of Tumor Tissue
Feasibility of the Maastro Applicator in Rectal Cancer
Dietary Supplements to Treat Radiation-Induced Rectal Injury
Evaluate the Distribution and Dynamic Behavior of Nuclide Labeled TH-SC01 Cells in Vivo in Patients With Radiation Proctitis
New Local Treatment of Radiation-induced Proctitis
The Effects of Probiotics Combined With Glutamine in the Prevention and Treatment of Radiation Proctitis
CryoSpray Ablation(TM)to Determine Safety and Feasibility in Radiation Induced Proctitis
Efficacy of Symbiotic in the Reduction of Acute Radiation Proctitis Symptoms
Budesonide Foam Versus Placebo for Prevention of Acute Radiation Proctitis
Study to Prevent Radiation Induced Damage to Bowel Using a Prebiotic Enhanced Diet.